Posts

Showing posts with the label High-Grade Glioma market forecast

High-Grade Glioma – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
  High-grade gliomas (HGGs) encompass various types of malignant brain tumors, including anaplastic astrocytomas, anaplastic oligoastrocytomas, glioblastoma multiforme (GBM), gliosarcomas, and anaplastic oligodendrogliomas, falling under WHO grades III and IV. They can originate directly from glial cells or from low-grade gliomas that transform into higher-grade malignancies. Patients with HGGs often exhibit a range of symptoms, such as memory dysfunction due to the tumor's invasive nature beyond the enhancing tumor boundaries. These symptoms may or may not aid in pinpointing the tumor's location. Family members and patients frequently recall personality changes and memory loss when discussing the patient's medical history. Headaches and vomiting are typically linked to increased intracranial pressure, with the headache's location being nonspecific. Seizures can be an initial symptom or manifest after diagnosis or during treatment. Neurological deficits correlate with...